首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   447篇
  免费   24篇
  国内免费   21篇
耳鼻咽喉   1篇
妇产科学   4篇
基础医学   14篇
口腔科学   16篇
临床医学   10篇
内科学   33篇
皮肤病学   4篇
神经病学   4篇
特种医学   14篇
外国民族医学   1篇
外科学   24篇
综合类   117篇
预防医学   13篇
眼科学   5篇
药学   39篇
中国医学   187篇
肿瘤学   6篇
  2024年   1篇
  2023年   5篇
  2022年   15篇
  2021年   19篇
  2020年   16篇
  2019年   45篇
  2018年   51篇
  2017年   26篇
  2016年   11篇
  2015年   11篇
  2014年   35篇
  2013年   21篇
  2012年   20篇
  2011年   27篇
  2010年   31篇
  2009年   20篇
  2008年   5篇
  2007年   13篇
  2006年   12篇
  2005年   7篇
  2004年   14篇
  2003年   11篇
  2002年   8篇
  2001年   5篇
  2000年   10篇
  1999年   4篇
  1998年   3篇
  1997年   4篇
  1995年   14篇
  1994年   2篇
  1993年   2篇
  1992年   3篇
  1991年   6篇
  1990年   1篇
  1989年   2篇
  1987年   1篇
  1983年   3篇
  1982年   1篇
  1981年   3篇
  1980年   2篇
  1976年   1篇
  1973年   1篇
排序方式: 共有492条查询结果,搜索用时 31 毫秒
41.
克百威的毒性及致突变性研究耿太保,李斌,王淑洁(中国预防医学科学院劳动卫生与职业病研究所,北京100050)克百威是广谱内吸杀虫剂和杀线虫剂。作者对国产克百威进行的急性毒性、蓄积毒性和致突变试验研究结果:纯品克百威对雄雌大鼠和雄性小鼠经口LD50分别...  相似文献   
42.
基于药物代谢组学的中药及方剂中组分间协同增效作用   总被引:1,自引:0,他引:1  
针对中药及方剂中多组分间配伍协同作用的特点,提出了利用药物代谢组学解析多组分间协同增效作用的机制的假说,并介绍了作者近期利用药物代谢组学研究方剂及组成药物相互关系的成果。  相似文献   
43.
刘完素的《三消论》是现存最早的消渴专书,另一本署名完素的著作《素问病机气宜保命集》中也有描写消渴诊治的专论,但比较此二论著的内容后,发觉其论述的角度迥异,不似由同一人所写,且目录学考证的结果或薄弱或分歧,无法辨别真伪。再借助于完素的《黄帝素问宣明论方》里消渴资料的分类比对,发现《三消论》和《宣明论方》的描述相当一致,此二书应当是出自刘完素之手。相对而言,《素问病机气宜保命集》的写作方式则明显不同于前二者,不大可能是刘完素的作品。  相似文献   
44.
45.
46.

Background

A longer time in consultation with doctors in ambulatory care has been associated with better quality of care. Patient experience is of great concern to policy makers and is linked with health-care quality. However, the relationship between consultation length and patient experience remains unclear. We aimed to investigate the effect of consultation length on patient experience, based on analysis of a cross-sectional nationwide patient survey data in China.

Methods

We obtained patient survey data from a strati?ed nationwide survey sample that covered 136 tertiary hospitals in China. Patient-estimated consultation length and associated patient experience data were collected by questionnaire after each patient attended a face-to-face consultation with a doctor. The consultation experience was rated on a 5-point scale. We applied a two-piecewise linear regression model to examine the saturation effect of the consultation length on patient experience (consultation score), using a smoothing function, while age, sex, education, and profession were adjusted in the model, then estimated the turning point that gave the maximum model likelihood by using trial and error.

Findings

Between Dec 18, 2017, and Dec 30, 2017, 27?721 patients, aged 15–85 years, were eligible and selected for inclusion. The median patient-reported duration of face-to-face ambulatory care consultation was 10 min (IQR 5–12), and the mean score of the consultation experience rated by the patient was 4·25 (SD 0·83; 95% CI 4·24–4·26) on the 5-point scale. After adjusting for potential confounders including age, sex, education, and profession, there was a non-linear relationship between consultation length and measure of patient experience after smooth curve fitting. A turning point at 8 min was identified in the modelling process. Below this point, there was a higher probability of rating a consultation score above average with longer consultation length (odds ratio [OR] 1·28, 95% CI 1·26–1·30, p<0·001). After this point, the OR changed to 1·03 (95% CI 1·02–1·04, p<0·001). There was a significant difference in patient experience measure before and after this consultation length turning point (p<0·001).

Interpretation

Consultation length was associated with a measure of patient experience in a non-linear pattern. Longer consultations might not be required to achieve better patient experience, but an adequate consultation should not be shorter than 8 min. Future research about the appropriateness of consultation length for varies ambulatory care institutions would be of benefit.

Funding

National Natural Science Foundation of China (71532014), National Health Commission of China  相似文献   
47.
目的 观察柴芍六君汤、拉米夫定联合治疗慢性乙型肝炎患者YMDD变异的情况.方法 采用非随机同期对照试验,将405例慢性乙型肝炎患者分为治疗组和对照组,治疗组220例,对照组185例,对照组给予拉米夫定100 mg,每天1次,口服,治疗18个月.治疗组给予柴胡六君汤每日1剂,同时口服拉米夫定100 mg,每天1次,治疗18个月.观察患者临床症状、ALT复常率、HBeAg阴转率,HBeAg血清转换率,HBV DNA阴转率、治疗12个月及18个月的YMDD变异率.率的比较采用χ2检验,均数比较采用t检验或U检验,方差不齐者用秩和检验. 结果治疗3.6、12.18个月时,ALT复常率治疗组分别为69.5%、85.9%、90.5%,82.7%,对照组分别为50.3%、65.4%、78.4%,69.7%,两组比较,χ2值分别为15.70、23.50、11.50.9.50.JD值均<0.01,差异均有统计学意义.治疗组12、18个月HBV DNA阴转率、HBeAg阴转率、HBeAg血清转换率、YMDD变异率分别为77.7%、57.7%、25.5%、6.8%和86.8%、74.1%、33.2%、8.6%,对照组分别为54.6%、36.8%,13.O%,14.6%和69.2%、37.3%、19.5%、20.5%,两组比较,χ2值分别为24.38、17.70、9.88、6.54和18.67、55.60、9.62,11.78,P<0.01或P<0.05,差异有统计学意义. 结论柴芍六君汤联合拉米夫定治疗慢性乙型肝炎,能有效地改善肝功能,提高拉米夫定抑制HBV复制的作用,减少YMDD变异的发生.  相似文献   
48.
金咏梅  赵滨  杨静 《上海中医药杂志》2015,49(12):50-51, 55
  目的:观察子午流注择时温和灸联合中药敷脐防治胃肠道恶性肿瘤化疗所致胃部不良反应的临床疗效。  方法:将120例胃肠道恶性肿瘤化疗患者随机分为对照组和观察组,每组60例。对照组患者在化疗期间常规给予制酸剂和止吐药物,观察组在对照组干预措施基础上,根据子午流注择时给予温和灸法和中药敷脐;观察两组患者胃部不良反应情况。  结果:化疗期间,观察组、对照组恶心、呕吐及食欲减退等胃部不良反应发生率分别为51.7%和80.0%,观察组胃部不良反应发生率及胃部症状分级均低于对照组(P<0.05)。  结论:子午流注择时温和灸联合中药敷脐能有效防治胃肠道肿瘤化疗所致的恶心、呕吐及食欲不振等胃部反应。  相似文献   
49.

Background

In China, patients increasingly choose to access severely overcrowded higher level hospitals, whereas the lower level facilities often have low frequencies of use. This situation undermines effectiveness and efficiency of the health system. Moreover, the situation tends to worsen despite policy measures aimed at improvement. We therefore aimed to systematically review the factors affecting patient choice of health system access in China to synthesise scientific understanding.

Methods

We did a systematic review of peer-reviewed literature that investigated Chinese patients' choice of health-care facilities at different levels. We searched Embase, MEDLINE, Web of Science, and PubMed for English language articles, and three large Chinese databases (CNKI, VIP, and Wanfang) for articles in Chinese between April 1, 2009, and Jan 28, 2016, using search terms related to patients' choice of health-care facility access level, and how these factors affect the choice of level, such as health care access, decision making in health care, and health seeking behaviour. The primary outcome was to identify the factors that influenced patient choices of health system access level in China. Two structured forms were used to extract data from eligible studies, regarding the study characteristics, methodology, and factors. We appraised the methodological quality of the studies using Method Appraisal Tool (MMAT).

Findings

We identified and included 45 studies into our analysis. We identified four types of factors related to patient, provider, context, and composite factors from multiple types. Patient factors are mentioned in 31 (69%) of 45 studies, but the evidence on patient factors is mostly inconclusive. Context factors were the least frequently mentioned, and were reported in four (9%) studies. Evidence suggests that the provider factors, such as drug variety and equipment, and composite factor, such as perceived quality, push patients from lower levels towards higher levels. The MMAT quality score was 100% for 13 studies, 75% for 25 studies, 50% for six studies, and 25% for one study.

Interpretation

This systematic review provides an evidence base for measures to redirect patient flow from high level health-care facilities to lower level facilities, thus improving effectiveness and efficiency of the Chinese health system. The underuse of primary care facilities in the Chinese health system compromises the effectiveness and efficiency, and are likely to be amplified by current demographic trends. Evidence suggests that improving the drug availability, equipment, and perceived quality of primary care services can improve the situation. Our evidence suggests that further experimental research is needed, which also considers interactions between factors.

Funding

This study was partly funded by the China Scholarship Council (grant number 201507720036).  相似文献   
50.

Background

China's Mental Health Law was implemented in 2013 to provide a legal foundation to protect patients' rights and provide involuntary treatment for patients at high risk of suicide or self-injury, or of harming others, or both. However, the law has not been thoroughly examined since its implementation. This study aimed to examine compliance of major psychiatric hospitals in China with the criteria of involuntary admission defined in the Mental Health Law.

Methods

As part of a national survey, we collected data from discharged inpatients from 32 tertiary psychiatric hospitals across all 31 provinces of China. We manually retrieved patients' admission information from discharge medical records, and calculated the proportion of the patients who met the criteria of involuntary admission.

Findings

We included data from 1663 (93%) of 1780 discharged inpatients from all hospitals. 814 (49%) of 1663 patients were admitted to hospital involuntarily. 369 (45%) of these 814 patients were admitted because of risks of suicide or self-injury, or of harming others, or both, as defined in the Mental Health Law. Among the 369 patients, 85 (23%) had risk of suicide or self-injury, 310 (84%) had risk of harming others, and 26 (7%) had both. The rest of the patients who were admitted involuntarily, although needing treatment, did not meet the Mental Health Law-defined criteria for involuntary admission.

Interpretation

The number of involuntary admissions in major psychiatric hospitals in China is high. Fewer than half of the patients who were admitted involuntarily met the criteria for involuntary admission, as defined by the Mental Health Law. Psychiatric hospitals and clinicians need to be mindful of balancing the safety of patients or others and avoiding the unnecessary restriction of patients' freedom.

Funding

Beijing Medical and Health Foundation.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号